Congress Proposes New Rules Requiring Doctors to Read Drug Warning Labels Before Medication Abortions
This bill is currently in the House Committee on Energy and Commerce where it has been since January 2026. No action has taken place on this proposal for about five months. The committee members must decide whether to move the bill forward, though most bills do not receive a vote at this stage.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Women seeking medication abortions from federally funded providers would face new mandatory disclosure requirements, including a 24-hour waiting period before the procedure. While the bill frames this as ensuring informed consent, the added steps and waiting period could delay access to care, particularly for women in rural areas or those who must travel long distances. The bill does not apply to miscarriage treatment or ectopic pregnancies.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.

Reporting from the annual March for Life in Washington D.C. on January 23, 2026, highlights the introduction of new federal legislation, including the Chemical Abortion Risk Awareness Act, as Republican lawmakers and activists shift focus toward further restricting medication abortion access.

Lawmakers in several states and Washington are pushing the Chemical Abortion Risk Awareness Act, which would require doctors to highlight risks and side effects of abortion pills. Critics argue the bill's real goal is to create legal liability for providers and reduce access to medication.
House Republicans have introduced the Chemical Abortion Risk Awareness Act, a bill that would force healthcare providers receiving federal funds to follow strict new disclosure rules for medication abortions. The bill includes a private right of action for patients to sue non-compliant clinics.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Chemical Abortion Risk Awareness Act
Analysis generated by AI. Always verify with official sources.